Valuation: Mirion Technologies, Inc.

Capitalization 5.51B 4.64B 4.23B 4.04B 7.5B 499B 7.79B 49.23B 19.54B 241B 20.65B 20.23B 842B P/E ratio 2025
213x
P/E ratio 2026 * 93.4x
Enterprise value 6.32B 5.32B 4.86B 4.64B 8.6B 572B 8.94B 56.47B 22.42B 276B 23.69B 23.21B 966B EV / Sales 2025
5.8x
EV / Sales 2026 * 5.45x
Free-Float
92.54%
Yield 2025 *
-
Yield 2026 * -
1 day+4.80%
1 week-6.48%
Current month-9.38%
1 month-14.25%
3 months-9.63%
6 months+9.06%
Current year-3.89%
1 week 20.84
Extreme 20.835
24.74
1 month 20.84
Extreme 20.835
27.49
Current year 20.84
Extreme 20.835
27.49
1 year 12
Extreme 12
30.28
3 years 6.7
Extreme 6.7
30.28
5 years 5.4
Extreme 5.4
30.28
10 years 5.4
Extreme 5.4
30.28
Manager TitleAgeSince
Chief Executive Officer 65 2021-10-19
President 50 -
Director of Finance/CFO 42 2019-12-31
Director TitleAgeSince
Director/Board Member 65 2021-10-19
Chairman 63 2021-10-19
Director/Board Member 65 2021-10-19
Change 5d. change 1-year change 3-years change Capi.($)
+4.80%-6.48%+38.10%+166.39% 5.51B
+4.54%+7.32%+151.51%+161.71% 17.51B
+0.72%+1.88%+137.18%+81.08% 10.41B
+2.24%+2.34%+108.07% - 9.96B
+0.20%+38.75%+77.08%+6.25% 9.74B
-0.55%-0.55%+14.15%+31.52% 7.74B
-1.59%+6.05%+66.73%+185.03% 6.95B
+6.45%+11.87%+121.90%+127.48% 5.71B
-3.85%+2.55%+94.03%+223.38% 5.36B
-2.23%+2.41%-28.73%+27.92% 4.56B
Average +1.07%+5.57%+78.00%+112.31% 8.35B
Weighted average by Cap. +1.54%+6.77%+92.99%+112.06%

Financials

2025 2026 *
Net sales 929M 783M 714M 682M 1.27B 84.16B 1.31B 8.31B 3.3B 40.64B 3.48B 3.41B 142B 1.13B 955M 871M 832M 1.54B 103B 1.6B 10.13B 4.02B 49.57B 4.25B 4.16B 173B
Net income 38.77M 32.67M 29.79M 28.44M 52.8M 3.51B 54.86M 347M 138M 1.7B 145M 142M 5.93B 66.4M 55.95M 51.03M 48.72M 90.44M 6.01B 93.97M 594M 236M 2.9B 249M 244M 10.15B
Net Debt 810M 683M 623M 595M 1.1B 73.4B 1.15B 7.24B 2.88B 35.44B 3.04B 2.98B 124B 669M 564M 514M 491M 911M 60.6B 947M 5.98B 2.37B 29.26B 2.51B 2.46B 102B
Logo Mirion Technologies, Inc.
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
Employees
3,000
Date Price Change Volume
26-02-13 22.51 $ +4.80% 5,218,327
26-02-12 21.48 $ +2.04% 7,006,549
26-02-11 21.05 $ -10.20% 9,697,985
26-02-10 23.44 $ -2.70% 3,502,331
26-02-09 24.09 $ +0.08% 2,304,501
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
22.51USD
Average target price
29.30USD
Spread / Average Target
+30.16%

Quarterly revenue - Rate of surprise